Inflammatory myopathies

Clinical features and prognosis of idiopathic inflammatory myopathy complicated by heart failure with preserved ejection fraction

Rheumatology (Oxford)Published Cohort study

Authors' conclusion

Our findings underscore the prognostic relevance of specific autoantibodies and cardiac fibrosis in IIM.

Study context

Population
Patients with idiopathic inflammatory myopathy (IIM) stratified by HFA-PEFF score
Participants
134 patients
Exposure
High-risk vs intermediate- and low-risk HFA-PEFF categories in IIM
  • High riskn = 22
Outcome
5-year survival
Follow-up
5 years
Methodological detailsstratified by HFA-PEFF score, Kaplan-Meier analysis, multivariable Cox regression
  • Stratified by HFA-PEFF score
  • Kaplan-Meier analysis
  • Multivariable Cox regression

Main finding

As reported in the abstract

P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeHRP value
All-cause mortality, HFA-PEFF ≥5 (multivariable Cox)High risk vs Low risk · independent predictor3.124P < 0.05
Late gadolinium enhancement on cardiac MRI in High risk
78.5%

Characteristics of High risk

Older, lower free triiodothyronine, higher CRP and cardiac troponin T (all P < 0.05); greater prevalence of ILD with advanced pulmonary fibrosis
Higher positivity for ANA, anti-SSA, anti-Jo-1 and anti-Ro52 (P < 0.05)

Original publication

Clinical features and prognosis of idiopathic inflammatory myopathy complicated by heart failure with preserved ejection fraction. Rheumatology (Oxford). Published 3 December 2025. doi:10.1093/rheumatology/keaf643

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.